Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...
This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...
A planned U.S.-funded study of a hepatitis B vaccine drew widespread condemnation from researchers. Now the host country says it cannot proceed.
The chair of a federal vaccine advisory panel charted a new course for the committee in a podcast released Thursday, ...
The U.S. is giving $1.6 million to researchers to study how the hepatitis B vaccine affects newborns in Guinea-Bissau. Local ...
In this Sept. 14, 2021, file photo, a syringe is prepared with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pa. Millions of U.S. workers now have a Jan. 4 ...
The unprecedented changes have led to diminished vaccine usage, and created a drag that will likely dent revenues.
Pfizer CEO Albert Bourla said that the main thing getting in the way of changing vaccine discussions in the U.S. is the ...
Sweeping changes to U.S. vaccine policy under Health Secretary Robert F. Kennedy Jr. are creating uncertainty across the pharmaceutical sector, dampening investor confidence and raising concerns among ...
Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 19.7% in the afternoon session after the company ...
In 2025's third quarter, multiple large vaccine developers, including Pfizer and GSK, saw vaccine sales tick up globally ...
Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results